Rand Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Rand Wealth’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$3.89M	Sell	40,532 -417	-1%	-$40.4K	0.44%	71
2018 Q2	$3.9M	Sell	40,949 -1,882	-4%	-$173K	0.44%	68
2018 Q1	$3.76M	Sell	42,831 -5,163	-11%	-$471K	0.42%	71
2017 Q4	$4.07M	Sell	47,994 -559	-1%	-$46.8K	0.45%	66
2017 Q3	$4.2M	Sell	48,553 -594	-1%	-$47.6K	0.48%	58
2017 Q2	$3.79M	Buy	49,147 +863	+2%	+$61.2K	0.51%	59
2017 Q1	$3.35M	Buy	48,284 +8,679	+22%	+$583K	0.4%	71
2016 Q4	$2.34M	Buy	39,605 +529	+1%	+$32.7K	0.3%	93
2016 Q3	$2.59M	Buy	39,076 +52	+0.1%	+$3.22K	0.34%	85
2016 Q2	$2.11M	Buy	39,024 +224	+0.6%	+$12.3K	0.29%	91
2016 Q1	$2M	Buy	38,800 +1,189	+3%	+$61.8K	0.28%	94
2015 Q4	$2.64M	Sell	37,611 -10,785	-22%	-$736K	0.37%	81
2015 Q3	$3.01M	Sell	48,396 -2,340	-5%	-$184K	0.44%	75
2015 Q2	$4.27M	Sell	50,736 -1,023	-2%	-$79.6K	0.58%	47
2015 Q1	$3.89M	Sell	51,759 -1,719	-3%	-$120K	0.52%	53
2014 Q4	$3.64M	Sell	53,478 -25,389	-32%	-$1.45M	0.5%	56
2014 Q3	$4.1M	Sell	78,867 -780	-1%	-$39.8K	0.59%	45
2014 Q2	$4.09M	Sell	79,647 -963	-1%	-$43.4K	0.59%	45
2014 Q1	$3.83M	Sell	80,610 -348	-0.4%	-$17.8K	0.66%	42
2013 Q4	$3.51M	Buy	80,958 +2,685	+3%	+$111K	0.62%	46
2013 Q3	$3.37M	Buy	78,273 +6,993	+10%	+$283K	0.67%	44
2013 Q2	$2.48M	Buy	+71,280	New	+$2.5M	0.54%	59

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Rand Wealth's XBI Position: Q3 2018 in Review

Rand Wealth reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 1% in Q3 2018, selling an estimated $40.4K and leaving 40,532 shares worth $3.89M. The position accounts for 0.44% of the portfolio, ranked #71.

Rand Wealth first reported a position in XBI in Q2 2013 and has held it in 22 quarters since. The position peaked at $4.27M in Q2 2015. 432 funds tracked by Wall St. Rank hold XBI as of Q3 2018.

Rand Wealth held 40,532 shares of State Street SPDR S&P Biotech ETF worth $3.89M as of Q3 2018.
Rand Wealth sold 417 State Street SPDR S&P Biotech ETF shares in Q3 2018, an estimated $40.4K.
State Street SPDR S&P Biotech ETF made up 0.44% of Rand Wealth's portfolio in Q3 2018, its #71 holding.
Rand Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 22 quarters since.
Rand Wealth's State Street SPDR S&P Biotech ETF position peaked at $4.27M in Q2 2015.
432 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2018.

Based on Rand Wealth's 13F filing for Q3 2018, filed 13 Nov 2018.